Bradford, J.M.W. (1990). The antiandrogen and hormonal treatment of sexual offenders. In W. L Marshall, D. R. Laws, & H. E. Barbaree (Eds.), Handbook of sexual assault: Issues, theories, and treatment of the offender (pp. 297-310). New York: Plenum Press.
2.
Davidson, J.M., Camargo, C., Smith, E.R., & Kwan, M. (1983). Maintenance of sexual function in a castrated man treated with ovarian steroids. Archives of Sexual Behavior , 12, 263-276.
3.
Heim, N., & Hursch, C.J. (1979). Castration of sex offenders: Treatment or punishment? A review and critique of recentEuropean literature. Archives of Sexccat Behavior, 8, 281-304.
4.
Maletzky, B.M. (1991). The use of medroxyprogesterone acetate to assist in the treatment of sexual offenders. Annals of Sex Research , 4, 117-129.
5.
Maletzky, B.M. (1993). Factors associated with success and failure in the behavioral and cognitive treatment of sexual offenders. Annals of Sex Research, 6, 241-258.
6.
McConaghy, N. (1993). Sexual behavior. Problems and management. New York: Plenum Press.
7.
Ortmann, J. (1980). The treatment of sexual offenders, castration, and antihormone therapy. International Joumal of Law and Psychiatry , 3, 443-451.
8.
Rousseau, L., Dupont, A., Labrie, F., & Couture, M. (1988). Sexuality changes in prostrate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration. Archives of Sexual Behavior, 17, 87-98.
